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Immuno-ﬂuorescenceA role for annexin A7 (A7) is postulated in the obligatory fusion between lamellar bodies and the plasma
membrane during surfactant secretion in alveolar type II cells. This study investigated if surfactant secreta-
gogues increase cell surface A7, which could support A7 insertion into plasma membrane as annexin proteins
reportedly lack membrane penetration ability. In vivo trafﬁcking of A7 to cell surface was determined by
immuno-staining after non-permeabilizing ﬁxation of alveolar type II cells. Stimulation with various secreta-
gogues increased protein kinase-dependent staining for A7 and ABCA3 in comparison to control cells.
Biotin-labeling of surface proteins showed ~4% of total A7 in control cells, which increased ~3–4 folds in
stimulated type II cells. Increased cell surface A7 was also observed by protein cross-linking studies showing
~70 kDa A7-adduct in the membranes but not in the cytosol fraction of PMA- or A23187-stimulated cells. In
vitro phosphorylation increased the Ca2+-dependent binding of recombinant A7 to lung plasma membranes;
and subsequent cross-linking showed increased levels of ~70 kDa A7-adduct. PMA-stimulation of type II cells
increased A7 trafﬁcking to lipid rafts suggesting that the latter are involved in A7 trafﬁcking to the cell surface.
However, in vitro membrane insertion of recombinant A7 and its tryptophanmutants as determined by ﬂuores-
cence quenching with doxylPC suggested only shallow membrane insertion by A7. Together, our studies
support in vivo association between surfactant secretion and cell surface A7 occurring by insertion into plasma
membrane and by fusion of A7 containing lamellar bodies.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Lung surfactant is vital for lowering surface tension at the alveolar
surface to prevent lung collapse during end-expiration. The principal
surface-active component phosphatidylcholine (PC) together with
surfactant proteins B and C, required for rapid recruitment and
surface-spreading of lipids, lowers the surface tension (reviewed in
[1]). All these components are synthesized in alveolar type II cells
and stored in the lamellar bodies for secretion into air space, which
occurs following lamellar body fusion with the plasma membrane.
Although several agents increase surfactant secretion through Ca2+
and protein kinase-regulatedmechanisms (reviewed in [2–4]), the reg-
ulatory processes for membrane fusion during surfactant secretion
remain relatively poorly investigated.
Several proteins are suggested to function during membrane fusion
between secretion vesicle and the plasma membrane. The classical and
most-investigated system involves proteins of the SNARE-complex
postulated to function in vesicle secretion during synaptic transmissiontony Brook University Medical
4 3031; fax:+1 631 444 8969.
nder).
l rights reserved.[5,6], a relatively rapid event in contrast with surfactant secretion [7].
Some of these proteins are also present in specialized cholesterol
and ganglioside-rich domains called lipid rafts in plasma membrane
of several cell types including type II cells [8,9]. The lipid rafts are
enriched in ﬂotillins [10] that are palmitoylated and myristoylated
plasma membrane-anchored proteins and are markers for lipid rafts
[8,10,11]. The lipid rafts are postulated to function in the endocytosis
and exocytosis functions of cells [8].
Several other proteins also function in membrane fusion during
exocytosis [12,13]. The membrane aggregation and membrane fusion
properties of annexin A7 (A7) and other annexin proteins play a role
in membrane fusion during exocytosis (reviewed in [14,15]). In alve-
olar type II cells, A7 and A2 proteins are involved in membrane fusion
for surfactant secretion [16–19]. We have previously suggested a role
for A7 in membrane fusion since it promotes surfactant secretion in
permeabilized type II cells [18] and shows in vitro interactions with
lipid vesicles [20] and cell membranes including lamellar bodies and
plasma membrane [21]. The stimulation of alveolar type II cells with
several secretagogues of lung surfactant increases membrane-
association of A7 [22]. The target membranes for A7 trafﬁcking in
stimulated type II cells include lamellar bodies and plasma mem-
branes, as demonstrated by in vitro binding [21] and by immuno-
ﬂuorescence co-localization with ABCA3 [22] and SNAP23 [23]. Such
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of A7 [22,23]. Together, these studies suggest a role for A7 in
membrane fusion during surfactant secretion.
Although trafﬁcking to lamellar bodies and SNAP23 domains sug-
gests a role for A7 in membrane fusion, further studies are required to
deﬁne if A7 could function as part of the fusion complex. Atomic force
and electron microscopy studies of lipid-associated annexin A5 or
annexin A2 proteins suggesting a planar nature for annexin proteins
[24–27] led to the conclusion that these proteins cannot insert into
membranes and, therefore, can have only supportive role(s) in mem-
brane fusion [28]. However, protein interactions with the speciﬁc
membrane lipids, which can regulate protein molecule organization
of annexin A7 [20,29,30] or annexin A1 [31], could affect protein
insertion into membranes. Alternately, association with proteins in
biological membranes or post-translational modiﬁcations of A7
could affect the planar conformation and thereby facilitate membrane
insertion. Therefore, we investigated if cell stimulation with surfac-
tant secretagogues would increase A7 at the cell surface, which
could be suggestive of its ability to penetrate plasma membrane.
Our studies employing various techniques suggest that surfactant se-
cretagogues increase A7 trafﬁcking to the cell surface through protein
kinase-dependent mechanisms. Phorbol myristate acetate (PMA) also
increased A7 trafﬁcking to lipid rafts in plasma membrane suggesting
their involvement in A7 appearance at the cell surface. However, in
agreement with others, in vitro biophysical studies suggested only
shallow membrane insertion by recombinant A7 proteins. Thus, we
speculate that stimulation with surfactant secretagogues increases
A7 phosphorylation to facilitate its association with the plasma mem-
brane and lamellar body proteins and appearance at the cell surface.
The latter is possibly mediated through A7 insertion into plasma
membrane or delivery during lamellar body fusion.
2. Materials and methods
2.1. Material
All cell culture supplies were obtained from Beckton Dickinson
(Sparks, MD) or from Cell Culture and Hybridoma facility at the Stony
Brook University (Stony Brook, NY). All ﬁne chemicals and reagents
were obtained from Sigma-Aldrich (St. Louis, MO). Lipids for vesicle
preparations were obtained from Avanti Polar Lipids (Alabaster, AL)
and were used without further puriﬁcation. The membrane-permeable
homobifunctional ethylene glycolbis(succinimidylsuccinate) (EGS)
and impermeable sulfo-EGS (S-EGS) protein cross-linking reagents
were used according to manufacturer's instructions (Pierce). Puriﬁed
brain PKC was obtained from Calbiochem (San Diego, CA). Actin
polyclonal antibodies were from Santa Cruz Biotechnology (Santa
Cruz, CA) and ABCA3 monoclonal antibodies were from Covance
(Gaithersburg, MD). Alexa-Fluor conjugated secondary antibodies
were obtained from Invitrogen (Grand Island, NY). Bacterially
expressed A7 full length protein was used for obtaining polyclonal anti-
bodies (rabbit) through commercial services and has been described
previously [22].
2.2. Isolation of alveolar type II cells
The use of rats for alveolar type II cell isolation [32] was according
to protocol approved by the Institutional Animal Care and Use Com-
mittee. Brieﬂy, male Sprague-Dawley rats (180–200 g) were anesthe-
tized with Nembutal (50 mg/kg, ip), tracheostomized and ventilated
with a rodent ventilator. The animal was sacriﬁced by exsanguina-
tions without the cessation of ventilation. Lungs were perfused
through pulmonary artery until visibly clear of residual blood, excised
and incubated at 37 °C following intra-tracheal instillation of porcine
elastase (3 units/ml). The lung lobes were separated and chopped
into 1 mm3 fragments on a tissue chopper. The lung fragmentswere vigorously shaken in buffer containing Ca2+, fetal bovine
serum (FBS) and DNase I to release free cells that were sequentially
ﬁltered (×3) through nylon cloth of decreasing mesh-size. The cell
suspension was enriched with type II cells by “panning” on rat
IgG-coated bacteriological culture dishes to remove macrophages.
Thus enriched cells (>85% type II cells by quinacrine staining [33])
were cultured for 20–22 h in minimum essential medium (MEM)
containing 10% FBS, during which period the cells adherent to tissue
culture plastic were routinely >90% alveolar type II cells.
2.3. Immuno-ﬂuorescence studies
The cell surface and intracellular localization of target proteins
was performed by immuno-ﬂuorescence studies in type II cells ﬁxed
without or with permeabilization. Routinely, cells were plated and
cultured for 20–22 h on poly-lysine coated glass cover slips. The
adherent cells were washed and treated with agents as indicated.
Thereafter, the cells were washed (3× for 5 min) in phosphate-
buffered saline (PBS) at room temperature and ﬁxed as indicated.
For non-permeabilization protocol, the cells were ﬁxed for 10 min
in 2% paraformaldehyde (PFA) at room temperature, and washed
(3× for 5 min) with PBS at 4 °C. The non-speciﬁc sites were blocked
by equilibration for 30 min at 4 °C with detergent-free blocking
buffer containing 10% donkey/goat serum and 1% BSA. For
permeabilizing protocol [23], the cells ﬁxed in 4% PFA for 10 min at
room temperature, washed (×3) and stored in PBS at 4 °C until
further processing. Before staining, the cells were simultaneously
blocked and permeabilized for 30 min in blocking buffer supplemented
with 0.1% Triton X-100 and 0.05% Tween 20 [23]. Following ﬁxation
and blocking, the cells were washed once in PBS and then sequential-
ly stained with primary (1:250) and secondary (1:500) antibodies,
1 h each, for the target proteins using polyclonal anti-rat A7 anti-
body and monoclonal anti-ABCA3 antibody. The respective second-
ary antibodies were anti rabbit Alexa568 anti mouse Alexa468
antibody (1:500).
2.4. Biotin labeling of cell surface proteins
Adherent 20–22 h cultured type II cells were washed, equilibrated
for 30 min in fresh serum-free MEM and incubated for 2 h without or
with indicated agents. The cell surface proteins were labeled using
the membrane-impermeable biotin labeling kit according to
manufacturer's instructions (Pierce, Rockford, IL) with slight modiﬁ-
cations. The cells were washed (×3) with PBS containing 0.1 mM
CaCl2 and 1 mM MgCl2. All subsequent steps were performed at
4 °C unless indicated. The cells were incubated for 2 h with
sulfo-NHS-SS-biotin (1.25 mg/ml) in 50 mM triethanolamine buffer
(pH 7.5) containing 2 mM MgCl2 and 150 mM NaCl. The cells were
washed (×3) with PBS and the reaction stopped by washing and equil-
ibration for 30 min on a rocker in 100 mM glycine in PBS. The cells
were washed (×2) with PBS and harvested by scarping in lysis buffer
(50 mM Tris buffer, pH 7.5, containing 150 mM NaCl, 5 mM EGTA, 1%
Triton X-100) containing 1 mM PMSF and leupeptin, pepstatin and
aprotinin (1 μg/ml each). The cell lysate was disrupted with a probe
sonicator (10 s×4, at 20% of maximum output) and incubated for 1 h
on ice with frequent mixing for further lysis. Equal aliquots of cell ly-
sates were centrifuged for 10 min at 16,100 g. The biotin-labeled pro-
teins in the supernatant were bound to NeutrAvidin™ beads (100 μl)
that were pre-washed (×4) and equilibrated in PBS. Equal volume of
cell lysate proteins (~500 μg) and beads was equilibrated overnight
at 4 °C with end-over-end mixing. The biotin-labeled proteins bound
to the beads were centrifuged, separated from the supernatant (the re-
sidual fraction), washed (×6) with PBS containing protease inhibitors
and equilibrated for 2 h at 4 °C in the elution buffer (62.5 mM Tris
buffer, pH 7.5 containing 50 mM DTT and 10% glycerol). Equivalent
proportions of the cell lysate, the residual fraction and the eluted
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analysis. The membranes were stained for 5 min in PonceauS (0.5% in
1% acetic acid) to assess the levels of transferred proteins.
In order to distinguish cell surface adherent A7 (possibly following
secretion and reattachment), type II cells treated without or with
PMA as indicated were incubated on ice for 30 min in 100 mM bicar-
bonate buffer (pH 11.5) as described previously [10]. The bicarbonate
soluble proteins in the supernatant were separated following centri-
fugation at 16,100 g for 60 min. The pellet was mixed with the cells
on the plate that were harvested by scraping in the lysis buffer (see
above). The relative levels of A7 in the cells and bicarbonate extract
were analyzed by western blotting and densitometry.
2.5. Cell surface protein cross-linking
Following incubation for 2 h without (control) or with 100 nM
PMA or 250 nM A23187, the cells were equilibrated for 2 h on ice in
the absence or presence of 2 mM S-EGS. The reaction was stopped
by equilibration for 30 min on ice with TEE buffer (50 mM Tris–HCl,
pH 7.4 containing 0.5 mM EGTA and 0.5 mM EDTA). The cells were
washed and scraped either in TEE buffer without (for cell fraction-
ation) or with 0.1% Triton X-100 (for cell lysis). Equal amounts of pro-
teins in the cell lysate or in the membrane and the cytosol fractions
were analyzed by western blotting for the detection of actin- or A7-
adducts.
2.6. A7 binding and cross-linking with lung plasma membrane proteins
Rat lungs visibly cleared of residual blood (see above) and dissect-
ed free of airways and other tissues were used for the isolation of
plasma membranes as described [34]. The Percoll® gradient puriﬁca-
tion was omitted because it reduces the yields. Brieﬂy, the lung lobes
were homogenized in ice-cold homogenization buffer (10 mM phos-
phate buffer, pH 7.4, containing 0.32 M sucrose, 1 mMMgCl2, 30 mM
NaCl, 1 mM PMSF, 0.02% NaN3 and 10 μg/ml DNase) using a tissue
disrupter (Model 5000, Omni International, Westbury, CT) and
Potter–Elvejahm type homogenizer. The homogenate was ﬁltered
through gauze and centrifuged for 1 h at 95,000 g through a discon-
tinuous gradient of 0.5, 0.7, 0.9 and 1.2 M sucrose in the homogeniz-
ing buffer. The interface between 0.9 and 1.2 M sucrose was diluted
to 0.2 M sucrose and centrifuged for 30 min at 95, 000 g to isolate
the plasma membrane enriched pellet, which was used for binding
and cross-linking studies.
The binding of recombinant A7 to plasma membrane was
performed as described for A7 binding to GST-SNAP23 beads in the
binding buffer [23], but omitting the NP-40 detergent. The plasma
membranes were washed and suspended in the binding buffer
(40 mM Hepes, pH 7.0, 100 mM KCl, 1 mM EGTA, 2 mM MgCl2,
1 mM Na3VO4, 1 mM PMSF, and 1 μg/ml each of leupeptin, aprotinin
and pepstatin). An aliquot of plasma membrane fraction (100 μg
protein) was equilibrated with A7 (1 μg), phosphorylated previously
for 2 h in the absence or presence of PKC [22]. The binding was
conducted at 4 °C for overnight in the absence or presence of 1 μM
Ca2+ buffered with EGTA by end-over-end mixing [35]. Subsequently,
the plasma membranes were centrifuged for 10 min at 16,100 g at
4 °C. The pellet was washed (×2) with the binding buffer containing
respective Ca2+ concentrations. The membranes were further washed
(×3), suspended in PBS and incubated for 30 min at room temperature
with 10 mMEGS for cross-linking of proteins. The reactionwas stopped
with ice-cold TEE buffer as described above and proteins were analyzed
for A7 by western blotting.
2.7. A7 in lamellar bodies
Since secretagogues increase A7 trafﬁcking to lamellar bodies, we
investigated the luminal and membrane-associated A7 in theseorganelles. The membrane-associated A7 was further distinguished
into the adherent and integral components. Lamellar bodies were iso-
lated from lung homogenate by upward ﬂotation on a discontinuous
sucrose gradient [36], disrupted in hypotonic sucrose (0.05 M) and
the lamellar body membrane fraction isolated by centrifugation
(100,000 g for 60 min) through 0.5 M sucrose [37]. The membranes
were incubated for 30 min on ice with 100 mM NaHCO3 buffer
(pH 11.5) and centrifuged for 60 min at 16,100 g to separate the
bicarbonate extract and the residual membranes. Equal aliquots of
lamellar bodies, bicarbonate extract and the residual membranes
were analyzed for A7 content by western blotting.
2.8. Lipid raft isolation
Isolated type II cells were stimulated without or with 100 nM PMA
and harvested in 1% Triton X-100-containing buffer as previously
described for PC12 cells [8] with some modiﬁcations. Brieﬂy, the
cells were washed with ice-cold PBS for further processing at 4 °C.
The cells were washed once with 20 mM Hepes buffer, pH 7.0
containing 255 mM sucrose, 1 mM EDTA, incubated for 20 min and
harvested in the same buffer supplemented with 1% Triton X-100
and the protease inhibitors (leupeptin, pepstatin and aprotinin, each
1 μg/ml, and 1 mM PMSF). The cells were further disrupted by
passage (8–10×) through 27G1/2 needle. Thus disrupted cells
(0.5 ml) were mixed with appropriate volume of 80% sucrose in
Hepes/EDTA buffer containing 1% Triton X-100 to yield 40% sucrose.
The ﬁnal suspension (1 ml) was placed at the bottom of the tube
and overlaid with 1 ml each of 30% and 15% and 1.5 ml of 5% sucrose
in the same buffer. After centrifugation for 18 h at 240,000 g, the pel-
let and 9 gradient fractions (0.5 ml each) were collected, and 20% of
each fraction was analyzed for the target proteins by western blot
analysis.
2.9. Bacterial expression of recombinant proteins
All recombinant proteins were expressed in Escherichia coli and pu-
riﬁed as described [20]. The single tryptophan residue (W239) in the
secondhomologous repeat of the COOH-terminus of A7was substituted
with phenylalanine to obtain tryptophan-free mutant, which formed
template for other DNA constructs for the expression of mutants with
selected phenylalanine residue (176, 339 or 443) in repeats I, III and
IV substituted with tryptophan. Thus, each mutant contained only one
tryptophan residue and acted as reporter for molecular changes in the
selected repeat during interaction with membranes.
2.10. Protein ﬂuorescence measurements
The tryptophan ﬂuorescence for the puriﬁed recombinant pro-
teins was measured in spectroﬂuorometer as previously described
[20]. Brieﬂy, the ﬂuorescence of ~0.5 to 1 μM protein solution (25–
50 μg/ml) in 50 mM Tris-acetate 1 mM EGTA (TAE) buffer (pH 8.3)
was measured (Exc.=292 nm, Em=310 to 400 nm, slit=4 nm
each). The solution was stirred at a low speed to ensure continuous
mixing without air bubble formation. All other additions were at
indicated ﬁnal concentrations. The ﬂuorescence spectra were
corrected for the volume and emission changes due to buffer or
other additions. All spectra were smoothed by 5 point averaging
and expressed as 5th polynomial ﬁt without or with normalization
of emission intensities.
2.11. Preparation of lipid vesicles
The lipid mixture with indicated composition (mol:mol) was pre-
pared using the appropriate proportions of stock solutions in chloro-
form:methanol (20:1). The lipid mixture was dried under a stream of
N2 and suspended in 50 mM Tris-Acetate-1 mM EGTA (TAE) buffer,
1247A. Chander et al. / Biochimica et Biophysica Acta 1833 (2013) 1244–1255pH 8.3, by vigorous mixing. The lipid suspension was sonicated
brieﬂy (3×10 s) at room temperature and passed (7–10) through
membrane ﬁlters (200 nm) in a membrane extruder. The vesicles
were stored overnight at 4 °C and centrifuged for 30 min at
16,100 g to sediment large aggregates. The small vesicles in the su-
pernatant were quantiﬁed for phospholipids by phosphorous analysis
[38].Fig. 1. Cell surface levels of A7 and ABCA3 are increased in secretagogue-stimulated
non-permeabilization (non-perm) do not immune-stain for intracellular protein actin, whi
and ABCA3 staining in control and PMA-stimulated (30 min) type II cells ﬁxed by permeabilz
for ABCA3 and A7 in type II cells, but the permeabilized cells showed higher staining. C. PM
cells were stimulated with 100 nM PMA for indicated periods and stained after ﬁxation by n
for up to 15 min. The co-localization was markedly increased after 30 min and was similar t
outlined areas in the respective upper panels. D. Protein kinase-dependence of increased ce
100 nM PMA, 1 mM ATP, 10 μM isoproterenol (Isoprel) or 250 nM A23187 without o
non-permeabilization protocol. Representative confocal images show staining intensity un
which demonstrates the inhibition of trafﬁcking by indicated protein kinase inhibitor. E. Th
of indicated determinations in parentheses. Results were compared by ANOVA followed b
with protein kinase inhibitor (H-89 for isoproterenol and BisI for all others).2.12. Lipid vesicle binding
Protein–lipid binding studies were carried out at room tempera-
ture. The binding was performed in TAE buffer in a total volume of
200 μl and contained 50 nmoles of phospholipid vesicles (PC:PE:PS:
cholesterol:PIP2, 42.5, 17.5, 25, 10, 5, mol%), 10 μg of recombinant
protein and indicated Ca2+ concentration buffered with 1 mMtype II cells in a protein kinase-dependent manner. A. Type II cells ﬁxed with
le those ﬁxed by permeabilization (perm) show actin staining. B. A comparison of A7
ation and non-permeabilization protocols. The PMA-stimulation increased the staining
A increases A7 and ABCA3 co-localization in a time-dependent manner. Isolated type II
on-permeabilization protocol. There was negligible co-localization of the two proteins
o that seen after 2 h of treatment with PMA. The lower panels show enlarged images of
ll surface staining for A7 and ABCA3. Isolated type II cells were stimulated for 2 h with
r with 30 min-preincubation with 100 nM BisI or H-89. The cells were ﬁxed by
der each condition. Enlarged view of outlined area in each image is shown as inset,
e weighted co-localization coefﬁcients for ABCA3 and A7 are expressed as mean±SE,
y post-hoc Tukey's test. * Pb0.05 in comparison to control, ** Pb0.05 in comparison
Fig. 1 (continued).
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followed by centrifugation for 10 min at 16,100 g. The pellet was
washed with TAE buffer without or with indicated Ca2+. The ﬁnal
pellet was suspended in 45 μl of TAE buffer and used for the quantiﬁ-
cation of phospholipids phosphorous and the protein.
2.13. Other analyses
Puriﬁed recombinant proteins were quantiﬁed by protein absor-
bance (A280, 1 mg/ml=1 OD). The proteins in the cell lysate or cellu-
lar fractions were quantiﬁed according to Bradford [39] using protein
dye binding reagent (Bio-Rad, Hercules, CA) and bovine γ-globulin as
standard. The puriﬁed recombinant proteins were characterized by
SDS-PAGE and stained with Coomassie Blue. The cell proteins were
analyzed for target proteins by western blotting using rabbit antibod-
ies to recombinant A7, actin or ﬂotillin-1, and images obtained with a
photoimager were analyzed by densitometry to compare relative
levels of target protein(s).
The confocal images were analyzed for co-localization of two pro-
teins using the software for the confocal microscope (Zeiss LSM510,
version 4.2 Program, Carl Zeiss Inc., Chester, VA), which allows the
calculations of co-localizing pixels above the threshold level in each
channel and calculation of the co-localization coefﬁcients (CCs). The
CC is weighted for the total pixels for each ﬂuorophore (weighted
CC), which is independent of the pixel intensity variations between
samples.
All statistical analyses were performed by GraphPad Prism (Version
5.0 for Windows, GraphPad Software, San Diego, CA). The weighted
CCs from several ﬂuorescencemicroscopy experiments were compared
to determine the effects of various agents. All results (mean±SE of
indicated number of determinations) were analyzed for statistical
signiﬁcance by ANOVA followed by Tukey's post-hoc test for the evalu-
ation of differences between different groups. P valuesb0.05 were con-
sidered signiﬁcant.
3. Results
3.1. Immuno-ﬂuorescence studies show A7 at cell surface
Preliminary studies showed the lack of actin staining in cells ﬁxed
by non-permeabilization protocol in contrast to those ﬁxed by
permeabilization protocol (Fig. 1A). Also, a comparison of A7 and
ABCA3 staining showed that the staining for ABCA3 was higher
in control cells ﬁxed by permeabilization protocol (Fig. 1B). As we
recently reported [22], control type II cells showed low co-
localization of the two proteins. PMA-stimulation for 30 min in-
creased the co-localization of A7 with ABCA3. In comparison,
non-permeabilized control cell showed lower staining for these
two proteins indicating that only small amounts of these proteins
were present at the cell surface. The PMA-stimulated cells, however,
showed increased cell-surface staining and co-localization for the
two proteins. Nevertheless, the increase was lower in comparison
with PMA-stimulated permeabilization-ﬁxed cells. Thus, the immuno-
staining studies demonstrated increased cell surface levels of A7 and
ABCA3 in PMA-stimulated type II cells.
The staining and co-localization of the two proteins were also
followed as a function of duration of cell stimulation with 100 nM
PMA (Fig. 1C). Although staining for A7 and ABCA3 increased after
5 and 15 min of treatment, a large increase in staining and
co-localization of the two proteins was observed only at 30 min,
which was similar to that after 2 h of stimulation. Selected areas of
co-localization are presented as higher magniﬁcation of areas marked
in upper panels. Similar increases were also observed in cells stimu-
lated for 2 h with 250 nM A23187, 1 mM ATP or 10 μM isoproterenol
(Fig. 1D, inset — marked area magniﬁed to show better view of
co-localization). Preincubation of cells for 30 min with respective
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Fig. 2. Biotin labeling shows the increased levels of cell surface-exposed A7 in secretagogue
1 mM ATP, 10 μM isoproterenol, 100 nM PMA or 250 nM A23187. The relative levels of A7
proteins), the residual fraction and the cell lysates. A. ATP and isoproterenol increase A7 l
of two proteins in each fraction. ii) PonceauS staining of membranes showing equivalent pr
for each condition. Densitometry showed that the cell surface A7 levels in the control, ATP
actin levels were similar in all groups, none was detected at the cell surface in any conditio
i) Western blot showing A7 and actin levels in the residual and surface fractions. ii) West
(notice proteins at ~40 and ~90 kDa, arrows) in the cell surface fraction, since actin
A23187-treated cells showed almost ~4-fold increase in the cell surface levels of A7 in
* Pb0.05 in comparison to PMA or A23187 by ANOVA and post-hoc Tukey's test. D. Cells were
the cell surface proteins were labeled with biotin. The presence of BisI blocked the PMA-stimu
cell surface A7 is also shown. E. Luminal A7 in lung lamellar bodies was determined by analyz
bodies (LB) isolated from lung homogenate by upward ﬂotation on discontinuous sucrose. The
proteins.Western blot analysis of the equivalent proportions of the three fractions shows thatm
A7was inserted in the limitingmembranes. F. Most cell surface A7 is not loosely attached to the
for 30 min on ice, centrifuged for 30 min at 16,100 g and the supernatant (wash) recovered. Th
alent proportions of cell lysate and thewash followed by densitometry indicated that only 0.8%
from biotin-labeling of cell surface proteins, the levels in bicarbonate wash were less than 10%The quantitative data for weighted co-localization coefﬁcients for
ABCA3 and A7 from several analyses showed that protein kinase
inhibitors diminished the co-localization of the two proteins (Fig. 1E).ii)
-stimulated type II cells. Isolated type II cells were stimulated for 2 h without or with
and actin were analyzed by western blotting of proteins from biotin-labeled (surface
evels at the cell surface. i) Western blots for actin and A7 showing the relative levels
otein loading (notice proteins at ~40 and ~90 kDa, arrows) in the cell surface fraction
and isoproterenol-treated cells were 6.6, 15.7 and 14.4% of the total cell A7. Although
n. B. Cell stimulation for 2 h with PMA and A23187 increases cell surface levels of A7.
ern membrane was stained with PonceauS to demonstrate equivalent protein loading
could not be detected. C. Densitometry analysis of western blots from PMA and
comparison to the controls. Results are mean±SE of experiments in parentheses.
incubated for 30 min with 100 nM BisI before incubation for 2 h with 100 nM PMA and
lated increase in A7 at the cell surface. For comparison, the A23187-mediated increase in
ing the relative distribution in the limiting membrane (LBM) and the total A7 in lamellar
isolated membranes were further treated with bicarbonate buffer to dissociate adherent
ost of the A7was luminal in lamellar bodies and that only a part of membrane-associated
cells. Control and PMA-stimulated (2 h) type II cells were treatedwith bicarbonate buffer
e pelletwas pooledwith the harvested cells from the plate.Western blot analysis of equiv-
and 1.7% of the total cell A7 could be recovered in thewash. A comparisonwith the results
of the biotin-labeled A7.
AB
Fig. 3. PMA and A23187 increase A7 interactions with cell surface proteins in type II cells.
A. Type II cells were stimulated for 2 h without (control) or with 100 nM PMA and the
cells were incubated in the absence or presence of membrane-impermeable cross-linker
sulfo-ethylene glycol bis(succinimidyl succinate) (S-EGS). Western analysis of cell lysate
(lys) shows A7-adduct (A7-add, arrow) in PMA-stimulated cells. The control cellswithout
or with cross-linking did not show A7-adduct. The lower panel shows actin levels but no
actin-adduct in these samples. B. Type II cells stimulated for 2 h without or with 100 nM
PMA or 250 nM A23187 were cross-linked with S-EGS and fractionated into the mem-
brane (M) and the cytosol (C) fractions. Western analysis showed that the membranes,
but not the cytosol, fraction contained higher levels of ~70 kDa A7-adduct (arrow) in
the PMA- or A23187-stimulated cells in comparison with the controls. This experiment
was conducted at least two times with both agents.
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Biotin labeling of cell surface proteinswithmembrane-impermeable
sulfo-NHS-SS-Biotin showed small amounts of A7 at the cell surface in
the control cells, which was increased in cells stimulated for 2 h with
1 mM ATP or 10 μM isoproterenol (Fig. 2Ai). Although equivalent
volumes of relevant fractions (8% for cell lysate and residual fractions
and 80% of the cell surface fraction) were used for analysis, equivalent
loading of proteins in the cell surface fraction (notably of proteins at
~40 and ~90 kDa, arrows) was also assessed from PonceauS staining
(Fig. 2Aii) because of the lack of actin in this fraction. Similarly the
increased levels of cell surface A7 were also observed in cells
stimulated for 2 h with 100 nM PMA or 250 nM A23187 (Fig. 2Bi),
although PonceauS staining showed equivalent protein levels in the
cell surface fractions (Fig. 2Bii, arrows). Densitometry analysis of
western blots from several experiments showed that approximately
4% of total cellular A7 was present at the cell surface, which increased
to almost 4-folds and 3-folds of the control levels in PMA or
A23187-treated cells, respectively (Fig. 2C). A7 trafﬁcking to cell surface
was mediated through PKC activation, since 30 min preincubation of
cells with 100 nM BisI blocked the increase in biotin-labeled A7 in
type II cells treated for 2 h with 100 nM PMA (Fig. 2D).
3.3. Lamellar body A7
Since cell stimulation with secretagogue increases A7 association
with the lamellar bodies, we analyzed the total and membrane-
associated A7 in isolated lung lamellar bodies, as these organelles
are unique to type II cells in the lung. Further, the yield from lung is
greater in comparison to that from isolated type II cells. We have
previously carried out extensive characterization of lamellar bodies
and lamellar body membranes [33,36,37]. Equivalent proportions of
various fractions were used for analysis and served as loading control.
Thus, the image reﬂects the relative distribution of A7 in each fraction
(Fig. 2E). The A7 in lamellar bodies was mostly luminal and only a
small amount was associated with the limiting membrane. Approxi-
mately, half of the membrane-associated A7 was adherent to
membranes as it could be extracted in the bicarbonate buffer.
Because surfactant secretagogues increase the secretion of lamellar
body contents (surfactant and possibly A7), we tested if reattachment
of secreted A7 to the cell surface could account for the cell surface A7
(as determined by biotin-labeling) in control and stimulated cells
(Fig. 2A and B). Bicarbonate extraction of cell surface adherent pro-
teins, previously used to demonstrate integral nature of ﬂotillin [10],
accounted for only 0.8% and 1.7% of total cellular A7 in control and
PMA-stimulated type II cells, respectively (Fig. 2F). Since these levels
were about 80–90% lower than for the biotin-labeled cell surface pro-
teins (Fig. 2C), we suggest that the contribution of A7 to the cell surface
pool by lamellar body secretion is relatively small in comparison to that
by other mechanisms including A7 insertion into plasma membrane.
3.4. Cross-linking of cell surface proteins
The cell surface levels of A7 were also studied by cross-linking of
cell surface protein using S-EGS, a membrane-impermeable cross-
linking agent with a wide spacer arm (16.1 Å). In initial studies
(Fig. 3A), cross-linking was performed in control and PMA-stimulated
cells and the cell lysates were evaluated for A7- and actin-adducts
(including dimers or oligomers). Although the control cells did not
show any adducts, the cells stimulated for 2 h with 100 nM PMA
showed an A7-adduct at ~70 kDa but none for actin (Fig. 3 A). In subse-
quent experiments, the surface proteins were cross-linked with S-EGS
and the cells were fractionated into themembrane and the cytosol frac-
tions. Western blot analysis showed ~70 kDa A7-adduct in the mem-
brane, but not in the cytosol fraction, of the PMA or A23187-treatedcells (Fig. 3B). Thus, A7 at the cell surface interacts with a protein
(~20 kDa) present in close proximity.
3.5. Lung plasma membrane binding and cross-linking of A7
Protein phosphorylation and Ca2+ increase A7 binding to type II
cell plasma membrane or SNAP23 [21,23]. In current study, binding
of recombinant A7 to lung plasma membrane was evaluated in the ab-
sence or presence of 1 μM Ca2+ following in vitro A7 phosphorylation
with PKC (Fig. 4). Additionally, the plasma membranes with the bound
protein were cross-linked to determine the direct interaction of A7
with other proteins in the plasma membrane fraction. The binding
was higher for PKC-phosphorylated A7 in the absence and presence
of 1 μM Ca2+, in comparison to the non-phosphorylated A7. The
cross-linking of membrane bound A7 resulted in the formation of sev-
eral adducts, one of which was about the same size as observed by
cross-linking of type II cell surface protein in the PMA- or A23187-
Fig. 4. PKC phosphorylation of A7 increases binding and interaction with lung plasma
membrane proteins. Recombinant A7 was phosphorylated in the absence or presence
of PKC and incubated for binding to lung plasma membrane fraction without or with
1 μM Ca2+ followed by protein cross-linking. Phosphorylation with PKC increased A7
binding to plasma membrane, which was further increased in the presence of 1 μM
Ca2+. The presence of A7-adducts (highlighted by vertical line in the right margin)
shows the interaction of A7 with several proteins. The A7-adduct at ~70 kDa (arrow)
is possibly the same as observed with type II cells. The two right lanes show the equiv-
alent levels of A7 in the binding mixture.
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~20 kDa A7-interacting protein is not recruited to the plasma mem-
brane on cell-stimulation (Fig. 3).3.6. PMA increases A7 trafﬁcking to lipid rafts
The endocytosis and exocytosis functions are postulated to involve
lipid rafts in plasma membrane that are enriched in cholesterol,
sphingolipids and gangliosides [8] and proteins like ﬂotillin and
t-SNARE proteins [8,10]. The lipid rafts, as judged by the marker
ﬂotillin-1, were present at the 30% and 15% sucrose inter-phase
(fractions 5 and 6) in control cells, while in PMA-stimulated cells
ﬂotillin-1 was distributed in fractions 5–7. PMA-stimulation of type II
cells also affected A7 distribution on the gradient showing increased
protein in fraction 5 in comparison to the control cells (Fig. 5). This
change in distribution was detected possibly because of the extra
layer of 15% sucrose between the 30% and 5% sucrose layers. Thus,
PMA-stimulation increases the trafﬁcking of A7 to ﬂotillin-1 containing
domains in type II cells.Fig. 5. PMA stimulation increases A7 trafﬁcking to lipid rafts in type II cells. Equal ali-
quots of fractions and the pellet from lipid rafts gradient from cells incubated for 2 h
without or with 100 nM PMA were analyzed for A7 and ﬂotillin-1 (lipid rafts marker).
Most of ﬂotillin-1 were present in fractions 5 and 6 in the control cells. PMA stimula-
tion causes the redistribution of ﬂotillin-1 into fractions 5–7. The arrow indicates the
gradient of 5% to 40% sucrose with fractions 1–3, 4 and 5, 6 and 7, and 8 and 9 belong-
ing to pre-centrifugation sucrose concentrations of 5, 15, 30 and 40%, respectively. In
comparison to control cells, A7 was enriched in fraction 5 in PMA-stimulated cells,
suggesting increased trafﬁcking of A7 to lipid rafts.3.7. Tryptophan protein ﬂuorescence of recombinant proteins
The crystal structure of mammalian A7 is not known. Previous
attempts with Dictyostelium discoideum A7 (later classiﬁed as annexin
C1 [40]) were successful in obtaining only a partial structure [41],
which showed homology with annexin A5, a protein with a short
NH2-terminus [42]. Therefore, we have shown the relative location
of the tryptophan and neighboring residues as linear peptide
(Fig. 6A) for each homologous repeat (I, F176W; II, W239 wild type;
III, F339W; and IV, F433W) [20]. Tryptophan in all repeats was pres-
ent in one of the helical regions (underlined), except in repeat I
[20]. All puriﬁed protein preparations showed a single ~47 kDa pro-
tein by SDS-PAGE analysis (Fig. 6B). The tryptophan-free A7W239F
and A7 showed similar calcium-dependent binding to phospholipid
vesicles (Fig. 6C). The binding of lipids increased with increasing
Ca2+ reaching a maximum at about 10 μM. Thus, tryptophan residue
is not critical for membrane binding of A7.
A comparison of ﬂuorescence scans (20–25 μg protein) showed
that the emission was due largely to the tryptophan residue in A7
and its three other mutants (A7F176W, A7F339W and A7F433W),
since very low ﬂuorescence was observed for mutant A7W239F
(Fig. 6D). The emission intensity and the emission peak differed for
each protein possibly due to the relative position of the tryptophan
residue and the quenching and enhancing effects of the neighboring
amino acids. The presence of 1 mM Ca2+ caused minor change in
the total ﬂuorescence for each protein (Fig. 6E). For all proteins, the
tryptophan residue was partially exposed to the aqueous phase as
suggested by acrylamide quenching of total ﬂuorescence — 15% for
the wild type (35.43 to 30.25), 27% for A7F176W (19.42 to 14.23)
and A7F443W (34.78 vs. 25.66) and 43% for A7F339W (59.3 to 33.7).
Our previous studies on protein tryptophan ﬂuorescence suggested
the NH2-terminus modulation of molecular organization of A7 and
its interactions with phospholipid membranes [20,29,30]. We also
demonstrated the ability of A7 to interact with trans-membranes as
determined by ﬂuorescence quenching of membrane-bound A7 with
dansyl-PE vesicles [29]. The ﬂuorescence quenching by dansyl moiety
in the polar head-group of PE, however, does not distinguishmembrane
association from insertion. The present study determined the mem-
brane insertion of A7 by measuring ﬂuorescence quenching with
doxylPC, a spin-labeled lipid where the nitroxide quencher group,
doxyl, is located in the fatty acid chain of the lipid [43]. The ﬂuorescence
emission of A7 was increased in presence of 20 μM PC:PS (1:1) vesicles
and 1 mMCa2+. In comparison, the ﬂuorescence was unchanged in the
presence of 1 mM Ca2+ and PC:PS vesicles containing 10% 7-doxylPC.
Similar studies with tryptophan mutants did not show any differences
in ﬂuorescence intensity with vesicles containing 0% or 10% 7-doxylPC
(Fig. 6F). Although these results suggested A7 insertion into mem-
branes, it did not appear deep since vesicles with 10% 12-doxylPC
(doxyl embedded deeper in the bilayer) did not cause ﬂuorescence
quenching for A7 or its mutants (not shown).4. Discussion
In this study, we demonstrate the trafﬁcking of A7 to the cell sur-
face in type II cells during the stimulated secretion of lung surfactant
and suggest possible insertion of A7 into the plasma membrane in
vivo. The cell surface A7 was increased with several agents that
increase surfactant secretion through different signaling mechanisms.
However, in vitro protein tryptophan ﬂuorescence studies with re-
combinant A7 and its tryptophan mutants did not provide a conclu-
sive evidence for A7 insertion into artiﬁcial membrane except for
possible shallow penetration. Thus, we suggest that in vivo mem-
brane insertion occurs possibly due to interaction with other proteins
or post-translational modiﬁcations like phosphorylation of A7, which
facilitate protein insertion into membranes. These observations
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secretion.
4.1. In vitro A7 interactions with artiﬁcial membranes
A7, like other annexin proteins, can bind to membranes in a
calcium-dependent manner and promote membrane fusion during
catecholamine secretion in charomafﬁn cells and lung surfactant secre-
tion in type II cells. The hypothetical scheme of membrane fusion
suggested the membrane binding of A7 followed by the reorganizationFig. 6. Protein ﬂuorescence quenching studies show the lack of membrane insertion by recom
position of the tryptophan (W) residue in each repeat. The underlined sequences denote he
F339W or F433W containing only a single tryptophan was expressed using the tryptophan-f
SDS gel of puriﬁed proteins shows the presence of a major protein at ~47 kDa. C. Ca2+-depe
icles were similar. D. Protein tryptophan ﬂuorescence of recombinant proteins shows the l
inﬂuenced by tryptophan location within the molecule as suggested by differences in emiss
in the absence and presence of 1 mM Ca2+ without or with 50 mM acrylamide. The spectr
5-point smoothing. Acrylamide quenching of ﬂuorescence indicates partial exposure of th
ﬁt) in the presence of 1 mM Ca2+ without or with 20 μM of indicated vesicles. Fluorescenc
parison to PC:PS (1:1) suggests shallow insertion by A7 through repeat II (W239), since noof membrane phospholipids around the protein molecules to form the
fusion pore [44] implying membrane insertion of A7. This important
phase of membrane fusion is supported by the ability of A7 to form cal-
cium channels in lipid membranes [45]. However, puriﬁed annexins A5
and A2 show only peripheral association with lipid bilayers as demon-
strated by ultrastructural and atomic force microscopy studies of the
lipid–protein complex [24,25]. Also, the thermodynamic aspects of con-
formational change and the lack of seven trans-membrane domains
argue against A7 function as conventional channel [28]. In agreement,
our in vitro studies with doxylPC vesicles show only shallowmembranebinant A7. A. Amino acid sequence for relevant regions in the repeats I–IV showing the
lical regions. Tryptophan at 239 is present in the wild type protein. The mutant F176W,
ree mutant A7W239F (not shown) as the template. B. Coomassie brilliant blue®-stained
ndence of recombinant A7 and tryptophan-free mutant A7W239F binding to lipid ves-
ack of ﬂuorescence in A7W239F and that the ﬂuorescence emission characteristics are
ion peaks and intensities. E. Fluorescence emission spectra of each recombinant protein
a were corrected for buffer and dilution and are presented as 5th polynomial ﬁt after
e tryptophan residue to the aqueous phase. F. Fluorescence spectra (5th polynomial
e quenching with 7-doxylPC containing lipid vesicles (PC:PS:7-doxylPC, 4:5:1) in com-
quenching was observed with PC:PS:12-doxylPC (4:5:1) vesicles (not shown).
Fig. 6 (continued).
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part of A7 trafﬁcking to cell surface could occur through penetration
into plasma membrane, possibly in cooperation with other proteins or
following phosphorylation during the stimulation of surfactant secre-
tion. Thus, A7 may have a more involved role in membrane fusion in
vivo.
4.2. Annexin A7 insertion into membranes in vivo
Despite physico-chemical studies with artiﬁcial membranes
suggesting the inability of annexin proteins (including A7) to insert
into artiﬁcial membranes (Fig. 6 and [24,25]), our in vivo studies
show that endogenous A7 likely inserts and traverses the plasma
membrane as revealed by immuno-ﬂuorescence (Fig. 1) and biotin-
labeling of cell surface proteins (Fig. 2). Some of the cell surface A7
could arise from its association with the lamellar bodies (this study
and [22,23]) during surfactant secretion. Although most of the A7 in
lamellar bodies were luminal (Fig. 2E), its release and reattachment
to the cell surface do not appear signiﬁcant because A7 concentra-
tions following release in the cell culture mediumwill be highly dilut-
ed. This is supported by the recovery of only a small amount of
cellular A7 in the bicarbonate wash (Fig. 2F) in comparison to that re-
covered as biotin-labeled A7 in control and stimulated cells (Fig. 2B
and C). Thus, only a small proportion of cell surface A7 could be de-
rived from lamellar body secretion, while the remaining is likely
through mechanisms including protein insertion into plasma mem-
brane. Also, the presence of A7 in lamellar body lumen (Fig. 2E) sug-
gests that A7 can insert into the lamellar body membrane. Finally, the
presence of A7 in detergent insoluble lipid rafts argues against mereassociation with the membranes (Fig. 5). Thus, contrary to the ﬁnd-
ings using artiﬁcial membrane and physical analysis showing the
lack of membrane insertion (Fig. 6 and [24,25]), in vivo studies sug-
gest that cellular A7 can likely insert and traverse biological mem-
branes under speciﬁc conditions.
4.3. Mechanisms of annexin A7 insertion into membranes
Stimulation of type II cells causing A7 trafﬁcking to lamellar bodies
and the presence of A7 in lamellar body lumen would suggest that the
secretion of lung surfactant, at best, could only partly function as a
mechanism for A7 trafﬁcking to the cell surface. The presence of lumi-
nal A7 in lamellar bodies also supports that A7 association with la-
mellar bodies is followed by insertion into the membranes and
transfer to the lipid (including anionic phospholipids)-rich interior
that bind A7 with high afﬁnity. The mechanisms regulating A7
insertion into various membranes are not clear, but two possibilities –
phosphorylation and interaction with other proteins – are considered.
Our studies thus far show that protein kinase-dependent phosphory-
lation of A7 may be predominant for its trafﬁcking either directly or
indirectly (through lamellar bodies) into the plasma membrane
(Figs. 1D and E, and 2D). The immuno-staining studies showing A7
trafﬁcking to non-lamellar body compartment(s) suggest that all of
the A7 in the plasmamembrane are not directed through the lamellar
bodies. Direct phosphorylation-dependent trafﬁcking of A7 to plas-
ma membrane can also occur as supported by in vitro and in vivo in-
teractions of A7 with SNAP23 [23] and by A7 binding to plasma
membrane (Fig. 4). Additional mechanism(s) for membrane insertion
may involve interaction with other membrane proteins (Fig. 3) or
Fig. 6 (continued).
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late membrane insertion following the phosphorylation of A7.
The increased A7 levels in lipid rafts (Fig. 5) in PMA-stimulated
cells suggests that other secretagogues may also promote A7 trafﬁck-
ing to lipid rafts, which may be accompanied by its insertion into
membranes and exposure at the cell surface, since all secretagogues
showed increased immuno-staining and biotin-labeling of A7
(Figs. 1 and 2). We propose that such trafﬁcking requires protein ki-
nase mediated phosphorylation, which alters A7 afﬁnity for mem-
branes [21,22,46]. Our in vitro binding and cross-linking studies also
suggest a role for A7 phosphorylation and Ca2+ for binding and inter-
actions with proteins in the plasma membrane as supported by the
formation of several adducts including the ~70 kDa adduct seen dur-
ing the cross-linking of cell surface proteins (Fig. 3). Although the in
vivo cross-linking studies do not quantify A7 levels at the cell surface,
the relative increase in ~70 kDa protein implies increased A7 at the
cell surface.
In conclusion, our studies show that the in vivo function of
annexin A7, and possibly other annexin proteins, is regulated by
protein phosphorylation and, possibly, by interaction with other
membrane proteins. The identiﬁcation of interacting proteins and in
vitro interactions using recombinant proteins without and with phos-
phorylation may help further understand the precise mechanism and
the function of A7 and other annexin proteins.Acknowledgements
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